Literature DB >> 7990116

Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives.

T G Gantchev1, H Ali, J E van Lier.   

Abstract

The 3-D quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) paradigm, which considers the primary importance of the molecular fields in biological recognition, is now widely used to analyze and predict receptor-binding properties of various ligands. CoMFA was applied to build 3-D QSAR models of substituted estradiol-receptor interactions, employing 3-D molecular databases of more than 40 molecules. Ligands included the 17 alpha-ethynyl- and isomeric 17 alpha (20E/Z)-(iodovinyl)estradiols and their 7 alpha-, 11 beta-, and 12 beta-methyl (-methoxy) and -ethyl (-ethoxy) derivatives as well as selected 2- and 4-halogenated analogs. The influence of different CoMFA descriptors was studied in order to achieve the highest possible cross-validated r2, as derived from partial least-squares calculations. Special emphasis was put on the analysis of the nature of H-bonding (donor/acceptor) interactions. The model with the best predictive performance (r2 = 0.895) was used to visualize steric and electrostatic features of the QSAR (standard deviation*coefficient contour maps) and to predict receptor-binding affinities (RBA) of substituted estradiols other than those included in the original database. Twenty-seven test molecules were selected, including five which had previously been reported by other investigators. For the latter, a very good correlation with literature RBA values was obtained, which together with the high cross-validated r2 provides evidence for the high predictive capacity of the model. Among the unknown structures, the model suggests several new substitutions to derive at reasonable affinity ligands for the estrogen receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990116     DOI: 10.1021/jm00050a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Free energies of ligand binding for structurally diverse compounds.

Authors:  Chris Oostenbrink; Wilfred F van Gunsteren
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-14       Impact factor: 11.205

2.  Semiempirical QSAR study and ligand receptor interaction of estrogens.

Authors:  F A Pasha; H K Srivastava; P P Singh
Journal:  Mol Divers       Date:  2005       Impact factor: 2.943

3.  The importance of molecular structures, endpoints' values, and predictivity parameters in QSAR research: QSAR analysis of a series of estrogen receptor binders.

Authors:  Jiazhong Li; Paola Gramatica
Journal:  Mol Divers       Date:  2009-11-17       Impact factor: 2.943

4.  Synthesis and evaluation of 11β-(4-substituted phenyl) estradiol analogs: transition from estrogen receptor agonists to antagonists.

Authors:  Robert N Hanson; Edward Hua; J Adam Hendricks; David Labaree; Richard B Hochberg
Journal:  Bioorg Med Chem       Date:  2012-05-07       Impact factor: 3.641

5.  Ab initio fragment molecular orbital study of ligand binding to human progesterone receptor ligand-binding domain.

Authors:  Takanori Harada; Kenji Yamagishi; Tatsuya Nakano; Kazuo Kitaura; Hiroaki Tokiwa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-03-11       Impact factor: 3.000

6.  Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach.

Authors:  Alessio Amadasi; Andrea Mozzarelli; Clara Meda; Adriana Maggi; Pietro Cozzini
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

7.  Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species.

Authors:  W Tong; R Perkins; R Strelitz; E R Collantes; S Keenan; W J Welsh; W S Branham; D M Sheehan
Journal:  Environ Health Perspect       Date:  1997-10       Impact factor: 9.031

8.  Computational study of estrogen receptor-alpha antagonist with three-dimensional quantitative structure-activity relationship, support vector regression, and linear regression methods.

Authors:  Ying-Hsin Chang; Jun-Yan Chen; Chiou-Yi Hor; Yu-Chung Chuang; Chang-Biau Yang; Chia-Ning Yang
Journal:  Int J Med Chem       Date:  2013-05-14

9.  Using three-dimensional quantitative structure-activity relationships to examine estrogen receptor binding affinities of polychlorinated hydroxybiphenyls.

Authors:  C L Waller; D L Minor; J D McKinney
Journal:  Environ Health Perspect       Date:  1995 Jul-Aug       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.